McAllister I L, Douglas J P, Constable I J, Yu D Y
Lions Eye Institute, Nedlands, Western Australia.
Am J Ophthalmol. 1998 Aug;126(2):219-29. doi: 10.1016/s0002-9394(98)00156-1.
To evaluate the complications of laser-induced chorioretinal venous anastomosis in nonischemic central retinal vein occlusion (CRVO) and to identify the associated risks.
A retrospective consecutive series of 91 eyes (91 patients) with nonischemic CRVO with a mean +/- SD duration of 15.0 +/- 15.2 weeks (range, 3 to 72 weeks )and corrected visual acuity reduced to 20/100 or less because of perfused macular edema were reviewed. All eyes had one or more anastomotic attempts using argon laser (combined with Nd-YAG laser in 46 eyes) and a minimum of 12 months of follow-up.
Successful chorioretinal venous anastomoses were created in 49 eyes (54%). Eighteen eyes (20%) had neovascular complications. These consisted of intravitreal, intraretinal, and subretinal neovascular membranes and were significantly associated with retinal ischemia (P < .001). There was avascular fibrous tissue proliferation at the anastomotic site in eight eyes (9%), and it was not associated with retinal ischemia (P = .727). No eye developed further capillary nonperfusion once an anastomosis became functional. A chorioretinal venous anastomosis was associated with improved vision (P < .001); 84% of eyes had an average +/- SD improvement of 4.3 +/- 3.8 lines (range, 2 to 20 lines), with the remaining 16% having no improvement or reduced vision.
The major vision-threatening complication of laser-induced chorioretinal venous anastomosis for nonischemic CRVO is neovascular membranes occurring at the anastomotic site; these are associated with retinal ischemia. Prompt laser photocoagulation to areas of retinal ischemia that develop after the anastomotic attempt has been made may reduce the risk and severity of this complication.
评估激光诱导脉络膜视网膜静脉吻合术治疗非缺血性中央视网膜静脉阻塞(CRVO)的并发症,并确定相关风险。
回顾性连续纳入91例(91只眼)非缺血性CRVO患者,平均病程为15.0±15.2周(范围3至72周),因黄斑水肿导致矫正视力降至20/100或更低。所有患眼均接受了1次或多次氩激光吻合术尝试(46只眼联合Nd-YAG激光),并至少随访12个月。
49只眼(54%)成功建立了脉络膜视网膜静脉吻合。18只眼(20%)出现新生血管并发症。这些并发症包括玻璃体内、视网膜内和视网膜下新生血管膜,且与视网膜缺血显著相关(P<0.001)。8只眼(9%)在吻合部位出现无血管纤维组织增生,其与视网膜缺血无关(P=0.727)。一旦吻合成功,没有患眼出现进一步的毛细血管无灌注。脉络膜视网膜静脉吻合与视力改善相关(P<0.001);84%的患眼平均视力提高了4.3±3.8行(范围2至20行),其余16%的患眼视力无改善或下降。
激光诱导脉络膜视网膜静脉吻合术治疗非缺血性CRVO的主要视力威胁性并发症是吻合部位出现新生血管膜;这些与视网膜缺血有关。在进行吻合尝试后,对出现的视网膜缺血区域及时进行激光光凝,可能会降低该并发症的风险和严重程度。